期刊文献+

同型半胱氨酸对外周血内皮祖细胞数量和功能的影响 被引量:11

Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood
下载PDF
导出
摘要 目的:观察同型半胱氨酸(Hcy)对外周血内皮祖细胞(EPCs)的影响。方法:密度梯度离心法获取外周血单个核细胞,将其接种在人纤维连接蛋白包被的培养板,培养7d后,收集贴壁细胞,加入不同浓度Hcy(10μmol/L、50μmol/L、100μmol/L和200μmol/L)干预一定时间(6h、12h、24h和48h)。多波长激光共聚焦显微镜鉴定FITC-UEA-Ⅰ和DiI-acLDL双染色阳性细胞为正在分化的EPCs,流式细胞仪检测其表面标志进一步鉴定EPCs,倒置荧光显微镜下计数。采用MTT比色法、改良的Boyden小室、粘附能力测定实验和体外血管生成试剂盒分别观察EPCs的增殖能力、迁移能力、粘附能力和体外血管生成能力。结果:Hcy呈量效和时效地减少EPCs数量,200μmol/LHcy作用24h后EPCs数量明显少于对照组(35.7±6.7vs62.5±10.6,P<0.01),并损害EPCs增殖(0.531±0.061vs0.328±0.055,P<0.01)、迁移(26.3±6.4vs6.4±3.7,P<0.01)、贴壁(33.1±8.1vs17.4±7.5,P<0.01)、和体外血管生成(25.4±9.1vs10.4±4.7,P<0.01)。结论:Hcy不但减少EPCs数量并损害其功能。 AIM: To investigate whether homocysteine (Hcy) has influences on endothelial progenitor cell (EPCs) number and activity from peripheral blood. METHODS: Total mononuclear cells (MNCs) were plated on fibronectin-coated culture dishes and cultured for 7 days, and then attached cells were stimulated with Hcy or vehicle control for 6 h, 12 h, 24 h and 48 h. The adhesion, proliferation, migration and in vitro vasculogenesis activity of EPCs were assayed, respectively. RESULTS: Incubation of isolated human MNCs with Hcy dose and time-dependently decreased the number of EPCs with maximum at 200 (μmol/L) for 24 hours (35.7±6.7 vs 62.5±10.6, P<0.01). In addition, Hcy impaired EPC proliferative (0.531±0.061 vs 0.328±0.055, P<0.05), migratory (26.3±6.4 vs 6.4±3.7, P<0.01), adhesive (33.1±8.1 vs 17.4±7.5, P<0.01) and vasculogenesis capacity (25.4±9.1 vs 10.4±4.7, P<0.01) in a dose and time-dependent manner. CONCLUSION: It is suggested that Hcy may result in the reduction of EPCs and decrease EPC functional activity.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2005年第7期1274-1278,共5页 Chinese Journal of Pathophysiology
基金 浙江省科学技术研究基金资助项目(No.021107613) 浙江省卫生科学研究基金资助项目(No.2003A043)
关键词 内皮细胞 高半胱氨酸 显微镜检查 共焦 冠状动脉疾病 Endothelial cells Homocysteine Microscopy, confocal Coronary disease
  • 相关文献

参考文献13

  • 1Woo KS, Qiao M, Chook P, et al. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention[J]. J Card Surg, 2002, 17(5): 432 -435.
  • 2Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk[J]. N Engl J Med, 2003, 348(7): 593- 600.
  • 3Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow - derived endothelial progenitor cells [ J ]. Circulation, 2002, 105 (25): 3017 -3024.
  • 4Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expranded endothelial progenitor cells for therapeutic neovascularization[ J]. Proc Natl Acad Sci USA, 2000, 97(7): 3422 - 3427.
  • 5Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease[J]. Circ Res, 2001, 89(1): E1-E7.
  • 6Tepper OM, Galiano DR, Capla JM, et al. Human endothelial progenitor cells from type Ⅱ diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures[J]. Circulation, 2002, 106: 2781- 2786.
  • 7Welch GN, Loscalzo J. Homocysteine and atherothrombosis[J]. N Engl J Med, 1998, 338(15): 1042- 1050.
  • 8李秀昌,胡燕燕,张运,李继福,李华,傅善基,陈玉国.血清同型半胱氨酸水平与冠心病严重程度相关性的探讨[J].山东医科大学学报,2001,39(4):301-303. 被引量:26
  • 9王战坤,郑良荣,王兴祥,陈君柱.同型半胱氨酸与冠状动脉病变的相关性[J].中华急诊医学杂志,2003,12(11):752-754. 被引量:16
  • 10Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis[J]. Science,1997, 275(5302): 964 - 967.

二级参考文献8

  • 1Verhoef P, Kok FJ, Kluijtmam LA, et al. The 677C-T mutation in the methylenetetrahydrofolate reductasc gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis, 1997, 132: 105-113.
  • 2Woo KS, Chook P, Lolin YI, ct ul. Folic acid improves arterial endotheliul function in adults with hyperhomocystinemia. J Am Coll Cardiol,1999, 34: 2002-2006.
  • 3Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst (e) inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation,1997, 96: 2542-2544.
  • 4Woo KS, Qiao M, Chook P, et al. Homocysteine, endothelial dysfunction, and coron aryartery disease: emerging strategy for secondary prevention. J Card Stag, 2002, 17: 432-435.
  • 5Woo KS, Chook P, Young RP, et al. New risk factors for coronary heart disease in Asia. IntJ Cardiol, 1997, 62: 39-42.
  • 6Refsum H, Ueland PM, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med, 1998, 49: 31-62.
  • 7Woo KS, Chook P, Chart LL, et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. Am J Med, 2002, 112: 535-539.
  • 8Graham IM, Da]y LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.JAMA, 1997, 277: 1775-1781.

共引文献38

同被引文献134

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部